NASDAQ: NXTS
Nexentis Technologies Inc Stock

$1.70-0.05 (-2.86%)
Updated Nov 19, 2026
NXTS Price
$1.70
Fair Value Price
N/A
Market Cap
$1.13M
52 Week Low
$1.70
52 Week High
$119.00
P/E
0.04x
P/B
0.09x
P/S
-30.02x
PEG
N/A
Dividend Yield
N/A
Revenue
-$68.00k
Earnings
-$11.43M
Gross Margin
72.1%
Operating Margin
14,602.94%
Profit Margin
16,804.4%
Debt to Equity
0.21
Operating Cash Flow
-$5M
Beta
0.84
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NXTS Overview

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NXTS's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Agricultural Input

Industry Rating
D
NXTS
Ranked
Unranked of 10

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$4.14C
$115.76C
$61.38C
View Top Agricultural Input Stocks

Be the first to know about important NXTS news, forecast changes, insider trades & much more!

NXTS News

Overview

Due Diligence Score

–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NXTS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NXTS is good value based on its earnings relative to its share price (0.04x), compared to the US market average (41.92x)
P/E vs Market Valuation
NXTS is good value based on its earnings relative to its share price (0.04x), compared to the US Agricultural Inputs industry average (12.26x)
P/E vs Industry Valuation
NXTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more NXTS due diligence checks available for Premium users.

Valuation

NXTS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0.04x
Industry
12.26x
Market
41.92x
NXTS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NXTS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NXTS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.09x
Industry
0.95x
NXTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NXTS's financial health

Profit margin

Revenue
$0.0
Net Income
$5.0M
Profit Margin
0%
NXTS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NXTS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$15.5M
Liabilities
$2.7M
Debt to equity
0.21
NXTS's short-term assets ($7.64M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NXTS's short-term assets ($7.64M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NXTS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NXTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$2.8M
Financing
-$770.0k
NXTS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NXTS vs Agricultural Input Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NXTS–$1.13M-2.86%0.04x0.09x
SEED–$7.87M-1.79%-0.65x-2.35x
BIOX–$11.68M-8.96%N/A0.50x
AVDD$20.39M-8.97%-0.33x0.13x
IPIC$394.25M-1.54%16.03x0.76x

Nexentis Technologies Stock FAQ

What is Nexentis Technologies's quote symbol?

(NASDAQ: NXTS) Nexentis Technologies trades on the NASDAQ under the ticker symbol NXTS. Nexentis Technologies stock quotes can also be displayed as NASDAQ: NXTS.

If you're new to stock investing, here's how to buy Nexentis Technologies stock.

What is the 52 week high and low for Nexentis Technologies (NASDAQ: NXTS)?

(NASDAQ: NXTS) Nexentis Technologies's 52-week high was $119.00, and its 52-week low was $1.70. It is currently -98.57% from its 52-week high and at its 52-week low.

How much is Nexentis Technologies stock worth today?

(NASDAQ: NXTS) Nexentis Technologies currently has 666,660 outstanding shares. With Nexentis Technologies stock trading at $1.70 per share, the total value of Nexentis Technologies stock (market capitalization) is $1.13M.

Nexentis Technologies stock was originally listed at a price of $60.76 in Oct 28, 2019. If you had invested in Nexentis Technologies stock at $60.76, your return over the last 7 years would have been -97.2%, for an annualized return of -40% (not including any dividends or dividend reinvestments).

How much is Nexentis Technologies's stock price per share?

(NASDAQ: NXTS) Nexentis Technologies stock price per share is $1.70 today (as of Nov 19, 2026).

What is Nexentis Technologies's Market Cap?

(NASDAQ: NXTS) Nexentis Technologies's market cap is $1.13M, as of Nov 20, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nexentis Technologies's market cap is calculated by multiplying NXTS's current stock price of $1.70 by NXTS's total outstanding shares of 666,660.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.